Na-Na Sun1, Chang Liu1, Xiao-Lin Ge2, Jie Wang2. 1. Departments of Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China. 2. Departments of Radiotherapy, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Abstract
PURPOSE: We aimed to evaluate the treatment response of patients with esophageal cancer after concurrent chemoradiation therapy (CRT) using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI). METHODS: This retrospective study included 59 patients with histologically confirmed esophageal squamous cell carcinoma. The patients underwent DCE-MRI before and 4 weeks after CRT. Patients with complete response were defined as the CR group; partial response, stable disease, and progressive disease patients were defined as the non-CR group. DCE-MRI parameters (Ktrans, Ve, and Kep) were measured and compared between pre- and post-CRT in the CR and non-CR groups, respectively. Pre-CRT and post-CRT parameters were used to calculate the absolute change and the ratio of change. DCE-MRI parameters were compared between the CR and non-CR groups. Receiver operating characteristic (ROC) curves were used to verify diagnostic performance. RESULTS: Patients with higher T-stage esophageal cancer might present with poorer response. After CRT, the Ktrans and Kep values significantly decreased in the CR group, whereas only Kep value decreased in the non-CR group. The post-Ktrans and post-Kep values were observed to be significantly lower in the CR group than in the non-CR group. The absolute change and ratio of change of both Ktrans and Kep were higher in the CR group than in the non-CR group. Based on ROC analysis, the ratio of change in Ktrans was the best parameter to assess treatment response (AUC= 0.840). CONCLUSION: DCE-MRI parameters are valuable in predicting and assessing concurrent CRT response for advanced esophageal cancer.
PURPOSE: We aimed to evaluate the treatment response of patients with esophageal cancer after concurrent chemoradiation therapy (CRT) using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI). METHODS: This retrospective study included 59 patients with histologically confirmed esophageal squamous cell carcinoma. The patients underwent DCE-MRI before and 4 weeks after CRT. Patients with complete response were defined as the CR group; partial response, stable disease, and progressive diseasepatients were defined as the non-CR group. DCE-MRI parameters (Ktrans, Ve, and Kep) were measured and compared between pre- and post-CRT in the CR and non-CR groups, respectively. Pre-CRT and post-CRT parameters were used to calculate the absolute change and the ratio of change. DCE-MRI parameters were compared between the CR and non-CR groups. Receiver operating characteristic (ROC) curves were used to verify diagnostic performance. RESULTS:Patients with higher T-stage esophageal cancer might present with poorer response. After CRT, the Ktrans and Kep values significantly decreased in the CR group, whereas only Kep value decreased in the non-CR group. The post-Ktrans and post-Kep values were observed to be significantly lower in the CR group than in the non-CR group. The absolute change and ratio of change of both Ktrans and Kep were higher in the CR group than in the non-CR group. Based on ROC analysis, the ratio of change in Ktrans was the best parameter to assess treatment response (AUC= 0.840). CONCLUSION:DCE-MRI parameters are valuable in predicting and assessing concurrent CRT response for advanced esophageal cancer.
Authors: Peter S N van Rossum; Astrid L H M W van Lier; Marco van Vulpen; Onne Reerink; Jan J W Lagendijk; Steven H Lin; Richard van Hillegersberg; Jelle P Ruurda; Gert J Meijer; Irene M Lips Journal: Radiother Oncol Date: 2015-05-19 Impact factor: 6.280
Authors: Quido G de Lussanet; Walter H Backes; Arjan W Griffioen; Anwar R Padhani; Coen I Baeten; Angela van Baardwijk; Philippe Lambin; Geerard L Beets; Jos M A van Engelshoven; Regina G H Beets-Tan Journal: Int J Radiat Oncol Biol Phys Date: 2005-08-26 Impact factor: 7.038
Authors: Sophie E Heethuis; Peter S N van Rossum; Irene M Lips; Lucas Goense; Francine E Voncken; Onne Reerink; Richard van Hillegersberg; Jelle P Ruurda; Marielle E Philippens; Marco van Vulpen; Gert J Meijer; Jan J W Lagendijk; Astrid L H M W van Lier Journal: Radiother Oncol Date: 2016-06-10 Impact factor: 6.280
Authors: Xiao Quan Xu; Young Jun Choi; Yu Sub Sung; Ra Gyoung Yoon; Seung Won Jang; Ji Eun Park; Young Jin Heo; Jung Hwan Baek; Jeong Hyun Lee Journal: Korean J Radiol Date: 2016-08-23 Impact factor: 3.500